Abstract deadline extended to MAY 2️⃣5️⃣th
RASopathies = genetic syndromes caused by dysfunctional RAS pathway signaling, affecting nearly all body systems.
Neurofibromatosis, Noonan syndrome, Costello syndrome #HRAS, CFC syndrome #rare
🧪 #pedsky #medsky #oncosky #cardiosky #neurosky #GI

Rarity Life Issue 12 Rarity Life is an online publication that offers those affected by rare disease, disability and cancer the opportunity to create content that is truly inclusive, to unify our collective experience and

#pedsky #medsky
Meet Helaina, 💃 ballroom dancer!
issuu.com/raritylife/d...
#Costello syndrome is a #RASopathy with mutations in the #HRAS gene. Probably only 1000-1500 people worldwide w/ this rare condition. For support & info go to costellokids.com

🔵 Lessons learned from public human rights assessments (HRAs) of generative AI.

🤝 Join ECNL's @marle.bsky.social , along with Lindsey Andersen of BSR, Betsy Popken and Vyoma Raman of Human Rights Center, UC Berkeley School of Law to reflect on their experiences conducting #HRAs of #GenAI.

Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies Abstract. Neurofibromatosis type 1 (NF1), Noonan syndrome, and related syndromes, grouped as RASopathies, result from dysregulation of the RAS-MAPK pathway and demonstrate varied multisystemic clinica...

Today, we are highlighting #CostelloSyndrome a rare #RASopathy caused by pathogenic #HRAS mutations, occurring ~1:380,000 births. Individuals with CS have a 13% ⬆️ risk of malignancy -> rhabdomyosarcoma, bladder carcinoma, and neuroblastoma. doi.org/10.1158/1078...
#oncosky #medsky #pedsky 🧪

Tipifarnib lives!!

#ASCO17 #HRAS #KRAS twitter.com/tomsilver39/status/87252...